|
|
Showing reports 1 - 10 of 26 in category Risk Governance, Health and Safety Issues:
| Approaches to Safe Nanotechnology |
| Source: National Institute for Occupational Safety and Health (NIOSH) – Publication date: July 2006 |
 | This document reviews what is currently known about nanoparticle toxicity and control, but it is only a starting point. The document serves as a request from NIOSH to occupational safety and health practitioners, researchers, product innovators and manufacturers, employers, workers, interest group members, and the general public to exchange information that will ensure that no worker suffers material impairment of safety or health as nanotechnology develops. |
|
| Approaches to Safe Nanotechnology (2009 Update) |
| Source: NIOSH – Publication date: March 2009 |
 | This document reviews what is currently known about nanoparticle toxicity, process emissions and exposure assessment, engineering controls, and personal protective equipment. This updated version of the document incorporates some of the latest results of NIOSH research, but it is only a starting point. The document serves a dual purpose: it is a summary of NIOSH's current thinking and interim recommendations; and it is a request from NIOSH to occupational safety and health practitioners, researchers, product innovators and manufacturers, employers, workers, interest group members, and the general public to exchange information that will ensure that no worker suffers material impairment of safety or health as nanotechnology develops. |
|
| Characterising the potential risks posed by engineered nanoparticles |
| Source: UK Department for Environment, Food and Rural Affairs (Defra) – Publication date: November 2005 |
 | This report published by the UK Government Department of Environment, Food and Rural Affairs (Defra) outlines the UK's research objectives to characterise the potential risks posed by engineered free nanoparticles and funding mechanisms to address these. |
|
| Characterising the Potential Risks posed by Engineered Nanoparticles - 2nd report |
| Source: UK Government – Publication date: December 2007 |
 | The Government has now published it's second research report Characterising the Potential Risks posed by Engineered Nanoparticles. This report builds on the 2005 report and 2006 progress report, providing an update on the Defra's Nanotechnology Research Co-ordination Group’s objectives and associated programme of work. |
|
| EMERGNANO |
| Source: Safenano – Publication date: March 2009 |
 | The EMERGNANO project, conducted under the umbrella of the SAFENANO initiative, identified more than 670 projects from around the world, and after careful selection assessed more than 260 unique, relevant projects completed, close to completion or in progress since 2004. The final report provides a comprehensive listing of projects, alongside detailed evaluation of their outputs. |
|
| EPA and Nanotechnology: Oversight for the 21st Century |
| Source: Project on Emerging Nanotechnologies – Publication date: May 2007 |
 | As the Environmental Protection Agency (EPA) recently stated, nanotechnology has evolved from a futuristic idea to watch to a current issue to address. A new report considers various oversight tools for dealing with nanotechnology and proposes a number of action steps for government, industry, and other stakeholders. |
|
| EPA's Nanotechnology White Paper |
| Source: U.S. Environmental Protection Agency – Publication date: February 2007 |
 | EPA's Science Policy Council has issued the Nanotechnology White Paper. The purpose of the White Paper is to inform EPA management of the science issues and needs associated with nanotechnology, to support related EPA program office needs, and to communicate these nanotechnology science issues to stakeholders and the public. |
|
| FDA Nanotechnology Task Force Report |
| Source: U.S. Food and Drug Administration – Publication date: July 2007 |
 | In 2006, the U.S. Food and Drug Administration (FDA) initiated the Nanotechnology Task Force to help assess if emerging nanotechnologies pose questions regarding the adequacy and application of the FDA regulatory guidelines. The Task Force'€™s initial findings were issued in this report. |
|
| Industrial application of nanomaterials - chances and risks |
| Source: VDI Technologiezentrum – Publication date: September 2004 |
 | The objectives of this report are to assemble available information from public and private sources on changes but also possible hazards involving industrial nanoparticle production, to evaluate the risks for workers, consumers and the environment, and to give recommendations for setting up regulatory measures and codes of good practice. |
|
| IRGC White Paper on Nanotechnology Risk Governance |
| Source: International Risk Governance Council – Publication date: June 2006 |
 | This White Paper is the first in which the IRGC publish recommendations for the risk governance of a particular problem field. The document begins with a brief description of nanotechnology and its likely future development both in terms of research and the types of product that it does and could support. The report categorized nanotechnology in two distinct but overlapping frames, one being for technologies and applications that are already on, or will shortly be available on, the market and the other being for the longer-term. Each of these frames poses a different set of risk governance concerns, although some concerns are common to both frames. |
|
|
|
|
|
|
